ES487062A0 - Procedimiento para preparar una vacuna inactivada de reo-vi-rus - Google Patents

Procedimiento para preparar una vacuna inactivada de reo-vi-rus

Info

Publication number
ES487062A0
ES487062A0 ES487062A ES487062A ES487062A0 ES 487062 A0 ES487062 A0 ES 487062A0 ES 487062 A ES487062 A ES 487062A ES 487062 A ES487062 A ES 487062A ES 487062 A0 ES487062 A0 ES 487062A0
Authority
ES
Spain
Prior art keywords
reo
rus
vaccine
inactivated
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES487062A
Other languages
English (en)
Other versions
ES8107026A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL7812359A external-priority patent/NL7812359A/nl
Priority claimed from NL7903299A external-priority patent/NL7903299A/nl
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES487062A0 publication Critical patent/ES487062A0/es
Publication of ES8107026A1 publication Critical patent/ES8107026A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES487062A 1978-12-20 1979-12-19 Procedimiento para preparar una vacuna inactivada de reo-vi-rus Expired ES8107026A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7812359A NL7812359A (nl) 1978-12-20 1978-12-20 Vaccins tegen door reo virus veroorzaakte ziektever- schijnselen en werkwijze voor het bereiden van deze vaccins.
NL7903299A NL7903299A (nl) 1979-04-26 1979-04-26 Vaccins tegen door reo virus veroorzaakte ziekte- verschijnselen en werkwijze voor het bereiden van deze vaccins.

Publications (2)

Publication Number Publication Date
ES487062A0 true ES487062A0 (es) 1980-12-16
ES8107026A1 ES8107026A1 (es) 1980-12-16

Family

ID=26645475

Family Applications (2)

Application Number Title Priority Date Filing Date
ES487062A Expired ES8107026A1 (es) 1978-12-20 1979-12-19 Procedimiento para preparar una vacuna inactivada de reo-vi-rus
ES494598A Expired ES8105150A1 (es) 1978-12-20 1980-08-29 Procedimiento para preparar una vacuna inactivada de reo-vi-rus

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES494598A Expired ES8105150A1 (es) 1978-12-20 1980-08-29 Procedimiento para preparar una vacuna inactivada de reo-vi-rus

Country Status (10)

Country Link
EP (1) EP0013449B1 (es)
CA (1) CA1136043A (es)
DE (1) DE2966648D1 (es)
DK (1) DK547279A (es)
ES (2) ES8107026A1 (es)
FR (1) FR2444467A1 (es)
GR (1) GR74012B (es)
IE (1) IE48722B1 (es)
LU (1) LU82018A1 (es)
PT (1) PT70556A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559229A (en) * 1982-07-20 1985-12-17 Research Foundation Avian proventriculitis vaccine
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US5525342A (en) * 1994-05-20 1996-06-11 Akzo Nobel, N.V. Reovirus strain 2177 and vaccine containing same
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6136307A (en) 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
EP2474714B1 (en) 2010-12-23 2013-04-03 C.R.F. Società Consortile per Azioni Internal combustion engine with wall masking the curtain area of the intake valves
CN116042537B (zh) * 2022-10-21 2024-09-20 乾元浩生物股份有限公司 禽呼肠孤病毒株qyh2020-qd、病毒液及制备方法、应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4823893B1 (es) * 1970-12-29 1973-07-17
NL7408579A (en) * 1974-06-26 1975-12-30 Philips Nv Vaccine against respiratory infections esp in horses - contg an adsorbed, killed suspension of reovirus in water

Also Published As

Publication number Publication date
ES494598A0 (es) 1981-05-16
IE792495L (en) 1980-06-20
DK547279A (da) 1980-06-21
CA1136043A (en) 1982-11-23
EP0013449B1 (en) 1984-02-08
FR2444467B1 (es) 1984-11-02
FR2444467A1 (fr) 1980-07-18
EP0013449A1 (en) 1980-07-23
PT70556A (en) 1980-01-01
ES8107026A1 (es) 1980-12-16
GR74012B (es) 1984-06-06
LU82018A1 (fr) 1981-07-23
IE48722B1 (en) 1985-05-01
DE2966648D1 (en) 1984-03-15
ES8105150A1 (es) 1981-05-16

Similar Documents

Publication Publication Date Title
AR228341A1 (es) Procedimiento para preparar 6-n-propil etil u 8-metoxi-metil,metil-mercaptometilergolinas,alil-8-metoximetil o metilmercapto metil o metilsulfonilmetil-ergolinas
AR223971A1 (es) Procedimiento para preparar un oxido de olefina
ES476994A0 (es) Procedimiento para preparar perhalociclopropanocarboxilatos.
AR219150A1 (es) Procedimiento para preparar nuevos derivados de aminoazucares
AR230989A1 (es) Procedimiento para preparar acilureidoalquil-bencen-sulfonilureas
ES490112A0 (es) Procedimiento de preparar oxazolidinationas
MX5604E (es) Procedimiento para preparar aril-hidantoina
ES492255A0 (es) Procedimiento para preparar aroilimidazol-2-onas
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
MX5721E (es) Procedimiento para preparar hidrazonas de benzofenona
MX147711A (es) Procedimiento para preparar una arcilla de esmectita intercalada
AR218304A1 (es) Procedimiento para la preparacion de una vacuna mejorada contra la enfermedad de newcastle
ES481478A0 (es) Procedimiento para preparar o-metaliloxifenol.
MX4221E (es) Procedimiento para la preparacion de una vacuna contra la hidrofobia
ES487062A0 (es) Procedimiento para preparar una vacuna inactivada de reo-vi-rus
AR221532A1 (es) Procedimiento para preparar una vacuna contra t.cruzi
AR230624A1 (es) Procedimiento para preparar omega-arcil(propionil o butiril)-l-prolinas substituidas
IT1122386B (it) Procedimento per preparare isopropenil-fenolo
ES478787A0 (es) Procedimiento para preparar acidos fenilalcanoicos.
MX4740E (es) Procedimiento para preparar una indol-dihidroindolcarboxamida dimerica
AR226210A1 (es) Procedimiento para preparar derivados de 2-benciliden-benzofuran-3-ona
NO783635L (no) Fremgangsmaate for fremstilling av influensavaksine
MX150040A (es) Procedimiento mejorado para preparar 3-metil-ciclopentadecanona
AR223177A1 (es) Procedimiento para preparar derivados de indolo-isoquinolina
MX5759E (es) Procedimiento para la preparacion de una vacuna contra el cancer

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506